A biomedical engineer at the University of Massachusetts Amherst used a nanogel-based carrier developed in his lab to deliver a medicine solely to the livers of obese mice, thereby curing their diet-induced disease
Diabetes is a chronic condition that affects one's capacity to regulate blood sugar levels. Many patients' conditions worsen over time, making blood sugar levels more difficult to control. Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide, have given patients greater con
Imagine getting the benefits of gastric bypass surgery without having to go under the knife -- a new class of compounds may be able to do just that. These potential treatments significantly reduce body weight and blood glucose levels in laboratory animals.